mTORC1/rpS6 and spermatogenic function in the testis—Insights from the adjudin model
Document Type
Article (peer-reviewed)
Publication Date
2019
Abstract
mTORC1/rpS6 signaling complex promoted Sertoli blood-testis barrier (BTB) remodeling by perturbing Sertoli cell-cell adhesion site known as the basal ectoplasmic specialization (ES). mTORC1/rpS6 complex also promoted disruption of spermatid adhesion at the Sertoli-spermatid interface called the apical ES. Herein, we performed analyses using the adjudin (a non-hormonal male contraceptive drug under development) model, wherein adjudin was known to perturb apical and basal ES function when used at high dose. Through direct administration of adjudin to the testis, adjudin at doses that failed to perturb BTB integrity per se, overexpression of an rpS6 phosphomimetic (i.e., constitutively active) mutant (i.e., p-rpS6-MT) that modified BTB function considerably potentiated adjudin efficacy. This led to disorderly spatial expression of proteins necessary to maintain the proper cytoskeletal organization of F-actin and microtubules (MTs) across the seminiferous epithelium, leading to germ cell exfoliation and aspermatogenesis. These findings yielded important insights regarding the role of mTORC1/rpS6 signaling complex in regulating BTB homeostasis.
Recommended Citation
Wu, Siwen, Ming Yan, Linxi Li, Baiping Mao, Chris K.C. Wong, Renshan Ge, Qing-Quan Lian, and C. Yan Cheng. 2019. "mTORC1/rpS6 and spermatogenic function in the testis—Insights from the adjudin model," Reproductive Toxicology 89: 54–66.
DOI
10.1016/j.reprotox.2019.07.002
Language
English